Protocol for a randomised feasibility study of Point-Of-care HIV viral load testing to Enhance Re-suppression in South Africa: the POwER study
<br><strong>Introduction </strong>Access to HIV viral load testing remains difficult for many people on antiretroviral therapy (ART) in low-income and middle-income countries. Weak laboratory and clinic systems often delay the detection and management of viraemia, which can lead to...
Main Authors: | Dorward, JJ, Sookrajh, Y, Ngobese, H, Lessells, R, Sayed, F, Bulo, E, Moodley, P, Samsunder, N, Lewis, L, Tonkin-Crine, S, Drain, PK, Hayward, G, Butler, CC, Garrett, N |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ
2021
|
Similar Items
-
Point-of-care viral load testing to manage HIV viraemia during the rollout of dolutegravir-based ART in South Africa: a randomised feasibility study (POwER)
by: Dorward, J, et al.
Published: (2023) -
Viremia and HIV drug resistance among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy
by: Dorward, J, et al.
Published: (2024) -
Diagnostic accuracy of the rapid Xpert HIV-1 Viral Load XC, Xpert HIV-1 Viral Load & m-PIMA HIV-1/2 Viral Load in South African clinics
by: Dorward, J, et al.
Published: (2022) -
Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy
by: Dorward, J, et al.
Published: (2023) -
Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir based antiretroviral therapy
by: Dorward, J, et al.
Published: (2023)